Management of yellow oleander poisoning

Clinical Toxicology

Volumn 47, Issue 3, 2009, Pages 206-212

  Rajapakse, Senaka ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Activated charcoal; Digitalis; Digoxin specific antibody fragments; Poisoning; Yellow oleander

Indexed keywords

ACTIVATED CARBON; ANTIEMETIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CHARCOAL; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIGOXIN ANTIBODY; ELECTROLYTE; GLUCOSE; HAYCARB; INSULIN; ISOPRENALINE; LIDOCAINE; MAGNESIUM; METOCLOPRAMIDE; ONDANSETRON; POLYSTYRENESULFONATE SODIUM; POTASSIUM; SALBUTAMOL; UNCLASSIFIED DRUG; ANTIDOTE; BLOCKING ANTIBODY; DIGOXIN; EMETIC AGENT; PLANT TOXIN;

BRADYCARDIA; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; DEHYDRATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY MONITORING; FLUID RESUSCITATION; HEALTH CARE COST; HEART ARRHYTHMIA; HEART PACING; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; MORTALITY; NONHUMAN; PATIENT COMPLIANCE; PLANT INTOXICATION; PROGNOSIS; REVIEW; RISK ASSESSMENT; STOMACH LAVAGE; SURVIVAL; SYSTEMATIC REVIEW; TACHYCARDIA; THEVETIA; THEVETIA PERUVIANA; TOTAL BODY POTASSIUM; TREATMENT DURATION; VOMITING; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; FLUID THERAPY; IMMUNOLOGY; LAVAGE; META ANALYSIS; METABOLIC DISORDER; NERIUM; PATHOPHYSIOLOGY; RESUSCITATION;

NERIUM; THEVETIA PERUVIANA;

ANTIBODIES, BLOCKING; ANTIDOTES; ANTIEMETICS; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; CHARCOAL; DIGOXIN; ELECTROCARDIOGRAPHY; EMETICS; FLUID THERAPY; HUMANS; IRRIGATION; NERIUM; ONDANSETRON; PLANT POISONING; POTASSIUM; RESUSCITATION; WATER-ELECTROLYTE IMBALANCE;

EID: 64049085760     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650902824001     Document Type: Review

References (55)

1. Eddleston M, Ariaratnam CA, Meyer WP, Perera G, Kularatne SAM, Attapattu S, Sheriff MHR, Warrell DA. Epidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in Northern Sri Lanka. Trop Med Int Health 1999; 4:266-273.
2. Eddleston M, Sheriff MHR, Hawton K. Deliberate self-harm in Sri Lanka: An overlooked tragedy in the developing world. BMJ 1998; 317:133-135.
3. Bose TK, Basu RK, Biswas B, De JN, Majumdar BC, Datta S. Cardiovascular effects of yellow oleander ingestion. J Indian Med Assoc 1999; 97:407-410.
4. Langford SD, Boor PJ. Oleander toxicity: An examination of human and animal toxic exposures. Toxicology 1996; 109:1-13.
5. Eddleston M, Ariaratnam CA, Sjöström L, Jayalath S, Rajakanthan K, Rajapakse S, Colbert D, Meyer WP, Perera G, Attapattu S, Kularatne SA, Sheriff MR, Warrell DA. Acute yellow oleander (Thevetia peruviana) poisoning: cardiac arrhythmias, electrolyte disturbances, and serum cardiac glycoside concentrations on presentation to hospital. Heart 2000; 83:301-306.
6. Sreeharan N, Putharasingam S, Ranjadayalan K, Satkurunathan K, Ganeshamoorthy J. Yellow oleander poisoning - clinical manifestations and prognostic criteria. Jaffna Med J 1985; 20:100-101.
7. Saravanapavananthan N, Ganeshamoorthy J. Yellow oleander poisoning - a study of 170 cases. Forensic Sci Int 1988; 36:247-250.
8. Fisch C, Surawicz B, eds. Digitalis. New York: Grune and Stratton; 1969.
9. Demiryurek AT, Demiryurek S. Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels. Auton Autacoid Pharmacol 2005; 25:35-52.
10. Lederer WJ, Tsien RW. Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres. J Physiol 1976; 263:73-100.
11. Mahdyoon H, Battilana G, Rosman H, Goldstein S, Gheorghiade M. The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J 1990; 120:1189-1194.
12. Gaultier M, Fournier E, Efthymiou ML. Intoxication digitalique aigue (70 observations). Bull Soc Med Hop Paris 1968; 119:247-274.
13. Kelly RA, Smith TW. Recognition and management of digitalis toxicity. Am J Cardiol 1992; 69:108-19G.
14. De Silva HA, Fonseka MM, Pathmeswaran A, Alahakone DG, Ratnatilake GA, Gunatilake SB, Ranasinha CD, Lalloo DG, Aronson JK, de Silva HJ. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: A single-blind, randomised, placebo-controlled trial. Lancet 2003; 361:1935-1938.
15. Hauptman PJ, Kelly RA. Digitalis. Circulation 1999; 99:1265-1270.
16. Ahee P, Crowe AV. The management of hyperkalemia in the emergency department. J Accid Emerg Med 2000; 17:188-191.
17. Oubaassine R, Bilbault P, Roegel JC, Alexandre E, Sigrist S, Lavaux T, Jaeger A, Pinget M, Kessler L. Cardio protective effect of glucose-insulin infusion on acute digoxin toxicity in rat. Toxicology 2006; 224:238-243.
18. Allon M. Treatment and prevention of hyperkalemia in endstage renal disease. Kidney Int 1993; 43:1197-1209.
19. Davey M. Calcium for hyperkalaemia in digoxin toxicity. Emerg Med J 2002; 19:183.
20. Hack JB, Woody JH, Lewis DE, Brewer K, Meggs WJ. The effect of calcium chloride in treating hyperkalemia due to acute digoxin toxicity in a porcine model. J Toxicol Clin Toxicol 2004; 42:337-342.
21. Fonseka MM, Seneviratne SL, De Silva CE, Gunatilake SB, De Silva HJ. Yellow oleander poisoning in Sri Lanka: outcome in a secondary care hospital. Hum Exp Toxicol 2002; 21:293-295.
22. Eddleston M, Juszczak E, Buckley NA, Senarathna L, Mohamed F, Dissanayake W, Hittarage A, Azher S, Jeganathan K, Jayamanne S, Sheriff MR, Warrell MA. Ox-Col Poisoning Study collaborators. Multiple- dose activated charcoal in acute self-poisoning: A randomised controlled trial. Lancet 2008; 371:579-587.
23. Stephens RH, O'Neill CA, Warhurst A, Carlson GL, Rowland M, Warhurst G. Kinetic Profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J Pharmacol Exp Ther 2001; 296:584-591.
24. Caldwell JH, Caldwell PB, Murphy JW, Beachler CW. Intestinal secretion of digoxin in the rat. Augmentation by feeding activated charcoal. Naunyn Schmiedebergs Arch Pharmacol 1980; 312:271-275.
25. Ibañez C, Carcas AJ, Frias J, Abad F. Activated charcoal increases digoxin elimination in patients. Int J Cardiol 1995; 48:27-30.
26. Chyka PA, Holley JE, Mandrell TD, Sugathan P. Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy. Ann Emerg Med 1995; 25:356-362.
27. Neuvonen PJ, Elfving SM, Elonen E. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol 1978; 13:213-218.
28. Lalonde RL, Deshpande R, Hamilton PP, McLean WM, Greenway DC. Acceleration of digoxin clearance by activated charcoal. Clin Pharmacol Ther 1985; 37:367-371.
29. Roberts DM, Southcott E, Potter JM, Roberts MS, Eddleston M, Buckley NA. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal. Ther Drug Monit 2006; 28:784-792.
30. De Silva HA, Pathmeswaran A, Lalloo DG, De Silva HJ, Aronson JA. Multiple-dose activated charcoal in yellow oleander poisoning. Lancet 2008; 371:2171-2172.
31. Eddleston M, Juszczakb E, Buckley NA. Multiple-dose activated charcoal in yellow oleander poisoning - authors' reply. Lancet 2008; 371:2171-2172.
32. Mohamed F, Senarathna L, Azher S, Sheriff MHR, Buckley NA, Eddleston M. Compliance for single and multiple dose regimens of superactivated charcoal: A prospective study of patients in a clinical trial. Clin Toxicol 2007; 45:132-135.
33. Jayamanne SF, Senarathna L, Dawson AH. Multidose activated charcoal in acute oleander poisoning - a longitudinal observational study. Ceylon Med J 2009; 54(Suppl 1) (in press).
34. Mangrum JM, DiMarco JP. The evaluation and management of bradycardia. N Engl J Med 2000; 342:703-709.
35. Bassani JW, Yuan W, Bers DM. Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol 1995; 268:C1313-C1319.
36. McCall E, Ginsburg KS, Bassani RA, Shannon TR, Qi M, Samarel AM, Bers DM. Ca flux, contractility, and excitation contraction coupling in hypertrophic rat ventricular myocytes. Am J Physiol 1998; 274:H1348-H1360.
37. Koretsune Y, Marban E. Cell calcium in the pathophysiology of ventricular fibrillation and in the pathogenesis of postarrhythmic contractile dysfunction. Circulation 1989; 80:369-379.
38. Lakatta EG, Guarnieri T. Spontaneous myocardial calcium oscillations: Are they linked to ventricular fibrillation? J Cardiovasc Electrophysiol 1993; 4:473-489.
39. Allen DG, Blinks JR. Calcium transients in aquorin injected frog cardiac muscle. Nature 1978; 273: 509-513.
40. Hussain M, Orchard CH. Sarcoplasmic reticulum Ca2+ content, L-type Ca2+ current and the Ca2+ transient in rat myocytes during adrenergic stimulation. J Physiol 1997; 505: 385-402.
41. Hancox JC, Levi AJ, Brooksby P. Intracellular calcium transients recorded with Fura-2 in spontaneously active myocytes isolated from the atrioventricular node of the rabbit heart. Proc R Soc Lond 1994; B255:99-105.
42. Brembilla-Perrot B, Muhanna I, Nippert M, Popovic B, Beurrier D, Houriez P, Terrier de la Chaise A, Claudon O, Louis P, Abdelaal A, State S, Andronache M, Suty-Selton C. Paradoxical effect of isoprenaline infusion. Europace 2005; 7:621-627.
43. Murphy JJ. Current practice and complications of temporary transvenous cardiac pacing. BMJ 1996; 312:1134.
44. Rajappan K, Fox KF. Temporary cardiac pacing in district general hospitals - sustainable resource or training liability? Q J Med 2003; 96:783-785.
45. Opie LH. Anti-arrhythmic agents in ischemic heart disease: supraventricular arrhythmias, digitalis toxicity and chronic stable ventricular ectopic beats. Methods Find Exp Clin Pharmacol 1982; 4:25-35.
46. Ma G, Brady WJ, Pollack M, Chan TC. Electrocardiographic manifestations: digitalis toxicity. J Emerg Med 2001; 20:145-152.
47. Wallace C. Magnesium. Emerg Med 2003; 15:92-96.
48. Kinlay S, Buckley NA. Magnesium sulphate in the treatment of ventricular arrhythmias due to digoxin toxicity. J Toxicol Clin Toxicol 1995; 33:55-59.
49. Eddleston M, Rajapakse S, Rajakanthan K, Jayalath S, Sjöström L, Santharaj W, Thenabadu PN, Sheriff MH, Warrell DA. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: A randomised controlled trial. Lancet 2000; 355:967-972.
50. Eddleston M, Senarathna L, Mohamed F, Buckley N, Juszczak E, Sheriff MH, Ariaratnam A, Rajapakse S, Warrell D, Rajakanthan K. Deaths due to absence of an affordable antitoxin for plant poisoning. Lancet 2003; 362: 1041-1044.
51. Smith TW, Haber E, Yeatman L, Bulter VP, Jr. Reversal of advanced digoxin intoxication with Fab fragments of digoxin specific antibodies. N Engl J Med 1976; 294:797-800.
52. Smith TW. Review of clinical experience with digoxin immune Fab (ovine). Am J Emerg Med 1991; 9:1-6.
53. Clerckx-Braun F, Kadima N, Lesne M, Mahieu P, Vandenbroucke JM. Digoxin acute intoxication: evaluation of the efficiency of charcoal hemoperfusion. Clin Toxicol 1979; 15:437-446.
54. Gilfrich HJ, Okonek S, Manns M, Schuster CJ. Digoxin and digitoxin elimination in man by charcoal hemoperfusion. Klin Wochenschr 1978; 56:1179-1183.
55. Wit AL, Janse MJ. The Ventricular Arrhythmias of Ischemia and Infarction: Electrophysiological Mechanisms. Mount Kisco, NY: Futura Publishing Co.; 1993.